DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Thongprasert S, Duffield E, Saijo N et al.
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
J Thorac Oncol 2011;
6: 1872-1880
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.